Safety and Tolerability of Azilsartan Medoxomil Plus Chlorthalidone Compared to Olmesartan Medoxomil Plus Hydrochlorothiazide in Participants With Essential Hypertension

Clinical trial NCT00996281 · COMPLETED

Trial details

NCT number: NCT00996281
Sponsor: Takeda
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Essential Hypertension

Start date: 2009-10-01
Primary completion: 2011-11-01
Enrollment: 837

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.